文献速递区域麻醉与超声术前评估与围术期医学

甲哌卡因与布比卡因腰麻对全膝关节置换术后运动功能恢复的比较:一项随机对照试验

Mepivacaine versus bupivacaine spinal anesthesia for return of motor function following total knee arthroplasty: a randomized controlled trial.
PubMed 文献 · Reg Anesth Pain Med · 2025-05-01

该随机对照试验纳入163例初次全膝关节置换患者,比较甲哌卡因60mg与等比重布比卡因10mg腰麻的效果。甲哌卡因组运动功能恢复中位时间更快(210分钟 vs 229分钟,p<0.001),尿潴留发生率更低(36% vs 57%,p=0.007),但未达到临床相关的20%缩短,且首次下地活动时间和当日出院率无差异。

要点

  • 甲哌卡因腰麻可加快运动功能恢复,但未达临床相关20%缩短。
  • 甲哌卡因组尿潴留发生率更低,但PACU疼痛评分更高。
  • 两组首次下地时间、当日出院率及术后6/24/48小时疼痛无差异。

核心结论

  • 甲哌卡因虽加快运动功能恢复,但未观察到临床相关的20%缩短,下地时间和当日出院率无差异。

研究设计与样本

  • 随机对照试验,纳入163例初次全膝关节置换患者,随机接受甲哌卡因60mg或等比重布比卡因10mg腰麻。

主要发现

  • 甲哌卡因组尿潴留发生率为36%,布比卡因组为57%,p=0.007。
  • 甲哌卡因组在麻醉后监护室(PACU)疼痛评分更高(32.4 vs 9.5 mm,p<0.001),但术后6、24、48小时无差异。
  • 两组阿片类药物消耗量在任何时间点均无差异(p=0.769)。
  • 首次下地时间、下地距离、当日出院率、住院时长、恶心呕吐、瘙痒及短暂神经症状均无差异。

临床怎么用

  • 对于需早期评估运动功能恢复的全膝关节置换患者,可考虑甲哌卡因腰麻,但需注意PACU疼痛评分较高。
  • 甲哌卡因可能降低尿潴留风险,但未能改善下地活动或当日出院率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Demand for same-day discharge pathways and early ambulation following knee arthroplasty continues to increase. While spinal anesthesia with mepivacaine versus bupivacaine may promote return of motor function and ambulation, there are limited randomized trials evaluating this in knee arthroplasty patients. This study hypothesized that spinal mepivacaine would result in earlier return of motor function, promoting ambulation and same-day discharge. METHODS: Patients undergoing primary total knee arthroplasty (n=163) were enrolled and randomized patients to mepivacaine (60 mg) or isobaric bupivacaine (10 mg) for spinal anesthesia. The primary outcome was time to return of motor function. Additional outcomes included time to first ambulation, distance at first ambulation, same-day discharge rate, length of stay, postoperative pain, opioid consumption, and side effects. RESULTS: Patients receiving a mepivacaine spinal anesthetic had faster median (95% CI) time to return of motor function, (210 min (200, 216) vs 229 (223, 237) min, p<0.001) and lower rates of urinary retention (36% vs 57%, p=0.007). Mepivacaine patients exhibited higher pain scores in the post-anesthesia care unit (32.4 vs 9.5 mm, p<0.001) but no differences at 6, 24, or 48 hours postoperative. Opioid consumption did not differ at any time point (p=0.769). There were no differences in time to first ambulation, distance at first ambulation, same-day discharge rate, length of stay, nausea, vomiting, pruritus, or transient neurological symptoms between groups. CONCLUSIONS: Although mepivacaine expedited return of motor function after knee arthroplasty, a clinically relevant 20% reduction was not observed. Ambulation times and same-day discharge rates did not differ. TRIAL REGISTRATION NUMBER: NCT05765682.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Pillow CF, Brewbaker C, Wolf BJ, et al. Mepivacaine versus bupivacaine spinal anesthesia for return of motor function following total knee arthroplasty: a randomized controlled trial. Reg Anesth Pain Med. 2025. PMID: 40316299. doi:10.1136/rapm-2024-106342

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。